US Patent

US10792262 — Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives

Method of Use · Assigned to Saol International Ltd · Expires 2039-07-29 · 13y remaining

Vulnerability score 62/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects stabilized formulations of 4-amino-3-substituted butanoic acid derivatives, including methods of manufacture and use.

USPTO Abstract

Pharmaceutical compositions including an active ingredient and a stabilizer, as well as methods of manufacture of the compositions, and methods of their use.

Drugs covered by this patent

Lioresal (BACLOFEN)

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-3263`	—	Lioresal
`U-3263`	—	Lioresal
`U-3263`	—	Lioresal

Patent Metadata

Patent number: US10792262
Jurisdiction: US
Classification: Method of Use
Expires: 2039-07-29
Drug substance claim: No
Drug product claim: Yes
Assignee: Saol International Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.